Diagnostic intervals exceeding 5 months and treatment delays of more than 2 months are significantly associated with unfavorable survival outcomes in LARC patients. These findings underscore the importance of timely diagnostic pathways and treatment initiation and may serve as clinically meaningful benchmarks for healthcare systems to optimize referral processes, resource allocation, and quality-of-care assessment in rectal cancer management.
Zhao et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: